These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37711678)

  • 1. Antibiotic resistance and the COVID-19 pandemic: A dual crisis with complex challenges in LMICs.
    Gulumbe BH; Sahal MR; Abdulrahim A; Faggo AA; Yusuf ZM; Sambo KH; Usman NI; Bagwai MA; Muhammad WN; Adamu A; Aminu U; Abubakar MT; Lawan KA
    Health Sci Rep; 2023 Sep; 6(9):e1566. PubMed ID: 37711678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing antimicrobial resistance in low and middle-income countries: overcoming challenges and implementing effective strategies.
    Rony MKK; Sharmi PD; Alamgir HM
    Environ Sci Pollut Res Int; 2023 Sep; 30(45):101896-101902. PubMed ID: 37610548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
    Tomczyk S; Taylor A; Brown A; de Kraker MEA; El-Saed A; Alshamrani M; Hendriksen RS; Jacob M; Löfmark S; Perovic O; Shetty N; Sievert D; Smith R; Stelling J; Thakur S; Vietor AC; Eckmanns T;
    J Antimicrob Chemother; 2021 Oct; 76(11):3045-3058. PubMed ID: 34473285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empowering Low- and Middle-Income Countries to Combat AMR by Minimal Use of Antibiotics: A Way Forward.
    Kanan M; Ramadan M; Haif H; Abdullah B; Mubarak J; Ahmad W; Mari S; Hassan S; Eid R; Hasan M; Qahl M; Assiri A; Sultan M; Alrumaih F; Alenzi A
    Antibiotics (Basel); 2023 Oct; 12(10):. PubMed ID: 37887205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How can we tackle the overuse of antibiotics in low- and middle-income countries?
    Sulis G; Sayood S; Gandra S
    Expert Rev Anti Infect Ther; 2023; 21(11):1189-1201. PubMed ID: 37746828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curbing antimicrobial resistance in post-COVID Africa: Challenges, actions and recommendations.
    Shomuyiwa DO; Lucero-Prisno DE; Manirambona E; Suleman MH; Rayan RA; Huang J; Zaw TN; Babatunde Y; Denkyira SA; Musa SS
    Health Sci Rep; 2022 Sep; 5(5):e771. PubMed ID: 35949681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges of COVID-19 in children in low- and middle-income countries.
    Zar HJ; Dawa J; Fischer GB; Castro-Rodriguez JA
    Paediatr Respir Rev; 2020 Sep; 35():70-74. PubMed ID: 32654854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drivers of inappropriate antibiotic use in low- and middle-income countries.
    Otaigbe II; Elikwu CJ
    JAC Antimicrob Resist; 2023 Jun; 5(3):dlad062. PubMed ID: 37265987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance in low- and middle-income countries: current status and future directions.
    Sulis G; Sayood S; Gandra S
    Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of COVID-19 on the non-COVID health outcomes of crisis-affected peoples: a systematic review.
    Thompson N; Kyaw KWY; Singh L; Cikomola JC; Singh NS; Roberts B
    Confl Health; 2024 Apr; 18(1):37. PubMed ID: 38664834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Drivers of Antimicrobial Resistance across the World.
    Vikesland P; Garner E; Gupta S; Kang S; Maile-Moskowitz A; Zhu N
    Acc Chem Res; 2019 Apr; 52(4):916-924. PubMed ID: 30848890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial stewardship in the era of the COVID-19 pandemic: A systematic review protocol on the opportunities and challenges for Sub-Saharan Africa.
    Njuma Libwea J; Ngwa CH; Ngomba AV; Wirsiy FS; Mpofu L; Ndongo CB; Koulla-Shiro S; Graham S; Djieuya LPT; Mandeng N; Mballa GAE; Sobh E; Nwaru BI; Ndombo PK; Epee E
    Medicine (Baltimore); 2023 May; 102(19):e33697. PubMed ID: 37171319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. It is complicated: Potential short- and long-term impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance-An expert review.
    Seneghini M; Rüfenacht S; Babouee-Flury B; Flury D; Schlegel M; Kuster SP; Kohler PP
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e27. PubMed ID: 36310817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Pandemic Impact on Academic Global Health Programs: Results of a Large International Survey.
    Rose ES; Rabin TL; Samaan J; Hudspeth JC; Ibrahim L; Azain MCP; Evert J; Eichbaum Q
    Ann Glob Health; 2022; 88(1):84. PubMed ID: 36247197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telehealth services for global emergencies: implications for COVID-19: a scoping review based on current evidence.
    Kissi J; Annobil C; Mensah NK; Owusu-Marfo J; Osei E; Asmah ZW
    BMC Health Serv Res; 2023 Jun; 23(1):567. PubMed ID: 37264401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flare of the silent pandemic in the era of the COVID-19 pandemic: Obstacles and opportunities.
    Rayan RA
    World J Clin Cases; 2023 Feb; 11(6):1267-1274. PubMed ID: 36926133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telemedicine in Low- and Middle-Income Countries During the COVID-19 Pandemic: A Scoping Review.
    Mahmoud K; Jaramillo C; Barteit S
    Front Public Health; 2022; 10():914423. PubMed ID: 35812479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000.
    Ashley EA; Recht J; Chua A; Dance D; Dhorda M; Thomas NV; Ranganathan N; Turner P; Guerin PJ; White NJ; Day NP
    J Antimicrob Chemother; 2018 Jul; 73(7):1737-1749. PubMed ID: 29514279
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.